RENALYTIX AI PLC-ADR (RNLX)

US75973T1016 - ADR

0.2071  +0.01 (+5.66%)

After market: 0.13 -0.08 (-37.23%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
1.491M2.97M
99.20%
3.403M
14.58%
5.05M
48.40%
10.302M
104.00%
18.988M
84.31%
EBITDA
YoY % growth
-30.515M
-210.30%
-54.759M
-79.45%
-39.863M
27.20%
-24.644M
38.18%
-16.463M
33.20%
-11.716M
28.83%
EBIT
YoY % growth
-32.611M
-194.38%
-57.372M
-75.93%
-42.355M
26.17%
-26.967M
36.33%
-18.685M
30.71%
-13.837M
25.95%
Operating Margin
-2,187.19%-1,931.72%-1,244.64%-534.00%-181.37%-72.87%
EPS
YoY % growth
N/A
-183.72%
N/A
-71.70%
N/A
40.32%
-0.23
59.30%
-0.13
42.86%
-0.12
8.33%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.09
38.46%
%
Q1 2024
Q2Q % growth
-0.12
62.17%
%
Q4 2023
Q2Q % growth
-0.11
74.99%
%
Q3 2023
Q2Q % growth
-0.14
64.23%
%
Q2 2022
Q2Q % growth
-0.41
-1,123.87%
0.43-0.85-194.86%
Q2 2021
Q2Q % growth

77.28%
-0.03%
Q2 2020
Q2Q % growth

-46.67%
-0.15%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
540K
-25.00%
%
Q4 2023
Q2Q % growth
520K
-68.35%
%
Q2 2023
Q2Q % growth
2.161M
62.85%
%
Q4 2022
Q2Q % growth
1.643M
50.60%
%
Q2 2022
Q2Q % growth
1.327M
231.75%
76.683M-75.356M-98.27%
Q2 2021
Q2Q % growth
400K 20.875M-20.475M-98.08%
Q2 2020
Q2Q % growth
2.301M-2.301M-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 6.97%
RevenueN/A N/A 0% 0%